Martin Lavoie
Dr. Martin Lavoie is a Canadian public health official based in Vancouver, British Columbia.
Career and Affiliations
Alberta Health Services
Lavoie was Medical Officer of Health for the David Thompson Health Region (DTHR) from 2002-2008. The DTHR reorganized into Alberta Health Services in 2008, where Lavoie continued into his new role as Senior Provincial Medical Officer of Health, and eventually Deputy Chief Medical Officer of Health until 2017.1) 2)
While at AHS, Lavoie advocated for people to get the influenza vaccines.3)
University of Alberta
Lavoie is an Assistant Clinical Professor in the Department of Medicine at the University of Alberta.
Fraser Health Authority
Lavoie worked for the Fraser Health Authority from August 2017 to July 2020. He started as the Executive Medical Director/Medical Officer of Health, then moved to Interim VP of Population Health and Chief Medical Officer of Health, then fully taking that position.4) 5)
Government of British Columbia
Lavoie is a Deputy Provincial Health Officer for the Government of British Columbia, serving under Dr. Bonnie Henry at the BC Ministry of Health.6) He began in this position in July 2020.7)
Public Health Agency of Canada
Lavoie is a liaison representative for the Council of Chief Medical Officers of Health on the National Advisory Committee on Immunization (NACI), the body responsible for recommending the approval of COVID-19 vaccines in Canada.8)
Research
Influenza
Lavoie has participated in research on H1N1 influenza, including in collaboration with the National Microbiology Laboratory under the Public Health Agency of Canada and the Centers for Disease Control and Prevention (CDC) in the United States.9)
Funding
Lavoie has participated in research funded by the Alberta Innovates Health Solutions Team Collaborative Innovation Opportunity. AI is partnered with Pfizer.10) Further funding has come from the Alberta Children's Hospital Research Institute, the Women and Children's Health Research Institute, and the Alberta Children's Hospital Foundation.
Presentations
Lavoie was a presenter at the British Columbia Pharmacy Association (BCPhA) 2021 Conference, where he discussed COVID-19 vaccines. The conference is sponsored by Abbott, AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Janssen, London Drugs, Merck, Pfizer, Pharmascience, Sandoz, Sanofi, Seqirus, Takeda, Trudell, and Unipharm.11)